Tracking outcomes after heart rhythm procedures in Düsseldorf.

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center registry at University Hospital Düsseldorf systematically collects retrospective and prospective clinical data on adults undergoing electrophysiological studies, catheter ablation, or electrical cardioversion. It records demographics, comorbidities, laboratory and imaging results, procedural details, and follow-up outcomes with scheduled visits at 1, 3, 6, 12, and 24 months and additional phone follow-up as needed. Primary endpoints focus on procedural safety (peri- and postprocedural complications, late adverse events) and efficacy (arrhythmia recurrence, repeat procedures, pacemaker implantation, or new medications), with secondary endpoints including hospitalization and all-cause mortality. Participation does not change routine diagnostic or therapeutic decisions and involves no additional invasive procedures.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients who undergo an electrophysiological study (EPS) or electrical cardioversion at University Hospital Düsseldorf since 2015 (retrospective cohort)
* Patients scheduled to undergo an EPS or electrical cardioversion at University Hospital Düsseldorf from 2019 onward (prospective cohort) •- Written informed consent for participation in the registry (prospective part only)

Exclusion Criteria:

* \< 18 years
* Lack of written informed consent
* Pregnancy

Where it's running

• University Hospital Duesseldorf
  Düsseldorf, Germany Recruiting

Study contacts

• Principal investigator: Obaida Rana, MD — Division of Cardiology, Pulmonary Disease and Vascular Medicine at University Hospital Duesseldorf
• Study coordinator: Obaida Rana, MD
• Email: obaida.rana@med.uni-duesseldorf.de
• Phone: +492118118800

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Early rhythm control treatment for subclinical atrial fibrillation

  This study tests whether starting rhythm-control treatments early can reduce abnormal heart rhythm episodes in people whose subclinical atrial fibrillation was found by implantable heart devices.

  Recruiting Samsung Medical Center · Seoul, Seoul · NCT07447297

• ICE-guided cavotricuspid isthmus ablation with a circular pulsed-field catheter

  This will see if a circular-shaped pulsed field ablation catheter, guided by intracardiac echocardiography, can safely and effectively achieve acute cavotricuspid isthmus ablation in adults with atrial fibrillation.

  Recruiting Beijing Anzhen Hospital · Beijing · NCT07353775

• Pulsed field ablation registry for atrial arrhythmias in Poland.

  This project will collect information to see how well pulsed field ablation works and how safe it is for people in Poland having ablation for atrial fibrillation, atrial flutter, or atrial tachycardia.

  Recruiting Wroclaw Medical University · Wroclaw, Lower Silesian Voivodeship · NCT07109141

• Catheter Ablation for Atrial Fibrillation and Ventricular Tachycardia: A Chinese Registry

  This registry follows adults with atrial fibrillation or ventricular tachycardia to see how well and safely catheter ablation works over time in real-world Chinese patients.

  Recruiting Beijing Anzhen Hospital · Beijing, Beijing Municipality and 1 other locations · NCT07024927

• Using a quick CT scan to check for left atrial clots before cardioversion in the Emergency Department

  This will test whether a rapid cardiac CT in the ED to look for left atrial clots lets people with symptomatic atrial fibrillation or flutter have safe same‑day cardioversion instead of being admitted or delayed.

  Recruiting at 3 sites Ottawa Heart Institute Research Corporation · Hershey, Pennsylvania and 2 other locations · NCT07002450

• Comparing LAA closure and anticoagulation for atrial fibrillation patients after brain bleeding

  This study is testing whether closing a part of the heart or using blood thinners is better for preventing strokes in patients with atrial fibrillation who have had a brain bleed.

  Recruiting at 29 sites Jena University Hospital · Mannheim, Baden-Wurttemberg and 38 other locations · NCT04298723

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.